Johnson Matthey PLC (LON:JMAT - Get Free Report) shot up 29% during mid-day trading on Friday . The stock traded as high as GBX 1,888 ($25.62) and last traded at GBX 1,792.32 ($24.32). 3,427,063 shares were traded during trading, an increase of 25% from the average session volume of 2,743,881 shares. The stock had previously closed at GBX 1,389 ($18.85).
Johnson Matthey Price Performance
The company has a 50 day simple moving average of GBX 1,313.40 and a 200-day simple moving average of GBX 1,377.22. The stock has a market cap of £2.85 billion, a price-to-earnings ratio of 28.96, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. As a group, research analysts anticipate that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Increases Dividend
The firm also recently announced a dividend, which was paid on Wednesday, April 16th. Investors of record on Thursday, April 10th were given a GBX 32 ($0.43) dividend. This is a boost from Johnson Matthey's previous dividend of $22.00. This represents a yield of 1.88%. The ex-dividend date was Thursday, April 10th. Johnson Matthey's dividend payout ratio (DPR) is currently 130.84%.
Insider Activity at Johnson Matthey
In related news, insider Liam Condon acquired 30 shares of Johnson Matthey stock in a transaction dated Wednesday, April 16th. The stock was acquired at an average cost of GBX 1,200 ($16.28) per share, with a total value of £360 ($488.47). Insiders have acquired a total of 75 shares of company stock worth $99,927 in the last three months. 0.61% of the stock is owned by company insiders.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Read More
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.